all age groups – Page 7 – Communicable Diseases Research

Humoral immunity to SARS-CoV-2 and seasonal coronaviruses in children and adults in north-eastern France

프랑스 북동부 어린이와 성인의 SARS-CoV-2 및 계절성 코로나바이러스에 대한 체액 면역

Research Paper

Published on 2021-07-232022-09-11
Journal: EBioMedicine [Category] MERS, SARS, 임상, 진단,

Cardiac Manifestations in COVID-19 Patients: A Focus on the Pediatric Population

Review Article

Published on 2021-07-162022-10-31
Journal: The Canadian Journal of Infectious Diseases & Medical Microbiology = Journal Canadien des Maladies Infectieuses et de la Microbiologie Médicale [Category] COVID-19,

Rhinovirus spread in children during the COVID‐19 pandemic despite social restrictions—A nationwide register study in Finland

Short Communication

Published on 2021-07-112022-11-01
Journal: Journal of medical virology [Category] COVID-19, Fulltext, MERS,

[키워드] affected age all age groups calculated children circulation coronavirus disease COVID‐19 Epidemiology Finnish FIVE highest incidence Influenza lifted looser Nonpharmaceutical interventions pandemic positive Prevent prevented recorded remained respiratory syncytial virus returned rhinovirus RSV Spread stratified Surveillance used data
[DOI] 10.1002/jmv.27180 PMC 바로가기 [Article Type] Short Communication

Changes in in-hospital mortality in the first wave of COVID-19: a multicentre prospective observational cohort study using the WHO Clinical Characterisation Protocol UK

Observational Study

Published on 2021-07-012022-10-04
Journal: The Lancet. Respiratory Medicine [Category] 임상,

[키워드] 95% CI A significant reduction accounted Admission all age groups all ethnic groups association assumed both sexes change changed changes in clinical Clinical sign Community Comorbidities Comorbidity confounder COVID-19 Critical care declined defined demographics died dose driver eligible England explained Factors finding First wave funding gradually increased group high risk hospital hospitalised patient identify Illness severity in-hospital mortality Infection ISRCTN registry knowledge Mediation analysis Medical Research Council Mortality multicentre natural effects model non-invasive ventilation Odds ratio Older outcome pandemic Patient patients patients with COVID-19 Primary outcome proportion prospective cohort prospective observational cohort recruited reduction reduction in Registered respiratory Respiratory Support risk RT-PCR test severe disease severity steroid treatment symptoms of COVID-19 the WHO use of steroid WHO with COVID-19
[DOI] 10.1016/S2213-2600(21)00175-2 PMC 바로가기 [Article Type] Observational Study

Vaccine Effects on Susceptibility and Symptomatology Can Change the Optimal Allocation of COVID-19 Vaccines: South Korea as an Example

Article

Published on 2021-06-252022-10-30
Journal: Journal of Clinical Medicine [Category] COVID-19,

SARS-CoV-2 Seroprevalence and Neutralizing Antibody Response after the First and Second COVID-19 Pandemic Wave in Croatia

Article

Published on 2021-06-202022-10-28
Journal: Pathogens [Category] COVID-19,

Exposures and suspected intoxications during SARS-CoV-2 pandemic: preliminary results from an Italian poison control centre

EM - Original

Published on 2021-06-062022-10-30
Journal: Internal and Emergency Medicine [Category] COVID-19, MERS, SARS,

A single-center observational study on clinical features and outcomes of 21 SARS-CoV-2-infected neonates from India

인도에서 온 21명의 SARS-CoV-2 감염 신생아의 임상 특징 및 결과에 대한 단일 센터 관찰 연구

Observational Study

Published on 2021-06-012022-09-11
Journal: European journal of pediatrics [Category] SARS, 임상, 치료기술,

[키워드] acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus-2 all age group all age groups antibodies caused Chain Reaction CK-MB Clinical characteristics clinical feature conditions coronavirus coronavirus disease Coronavirus disease-19 Coronavirus-2 Course COVID-19 creatine creatine kinase demonstrated elevated evaluated gastrointestinal system gastrointestinal systems IgM antibodies IgM antibody implication incidence India Infection intensive care invasive ventilation knowledge Laboratory parameters Lactate lactate dehydrogenase LDH Long-term follow-up Low-middle income management manifestation morbidity and mortality MOST Nasopharyngeal swab natural history Neonatal neonatal period Neonate Neonates Newborn Non-invasive observational study outcome outcomes overlap pandemic parameter positive required retrospective reverse transcriptase RT-PCR SARS-CoV-2 SARS-COV-2 infection Severe acute respiratory syndrome severe acute respiratory syndrome Coronavirus severe acute respiratory syndrome coronavirus-2 single-center subset suggested supportive care Supportive treatment surfactant Surfactant instillation term Treatment vulnerable population with COVID-19
[DOI] 10.1007/s00431-021-03967-7 PMC 바로가기 [Article Type] Observational Study

Evaluation of Serologic Changes of IgG and IgM Antibodies Associated with SARS-COV-2 in Cancer Patients: A Cohort Seroprevalence Study

암 환자에서 SARS-COV-2와 관련된 IgG 및 IgM 항체의 혈청학적 변화 평가: 코호트 혈청 유병률 연구

Short Communication

Published on 2021-06-012022-09-01
Journal: Asian Pacific Journal of Cancer Prevention : APJCP [Category] 진단,

[키워드] age all age group all age groups anticancer Asymptomatic asymptomatic infections asymptomatic patient Cancer cancer patient Cancer patients change cohort study coronavirus disease Coronavirus disease 2019 COVID-19 COVID-19 symptom COVID-19 symptoms COVID-19 transmission COVID-19- SARS-CoV-2- cancer- oncology- asymptomatic determine diagnostic disease elevated ELISA enrolled enzyme enzyme-linked immunosorbent enzyme-linked immunosorbent assay Epidemic evaluated Evidence General population IgG and IgM Infection investigated morbidity morbidity and mortality outbreak pandemic spreads Patient positive Remission risk SARS-CoV-2 SARS-CoV-2 antibodies SARS-CoV-2 antibody SARS-COV-2 infection Seroconversion serologic serological test Serologically serology testing Seropositivity Seroprevalence serum sample serum samples Sex the SARS-CoV-2 therapy while
[DOI] 10.31557/APJCP.2021.22.6.1667 PMC 바로가기 [Article Type] Short Communication

Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: an observational study using national surveillance data

이스라엘의 전국적인 예방접종 캠페인에 따른 SARS-CoV-2 감염 및 COVID-19 사례, 입원 및 사망에 대한 mRNA BNT162b2 백신의 영향 및 효과: 국가 감시 데이터를 사용한 관찰 연구

Observational Study

Published on 2021-05-152022-09-11
Journal: Lancet (London, England) [Category] Fulltext, SARS, 변종, 임상,

[키워드] 95% CI adjusted age all age group all age groups Analysis Asymptomatic asymptomatic infection authorisation B.1.1.7 B.1.1.7 SARS-CoV-2 variant B.1.1.7 variant BNT162b2 calculated caused Coverage COVID-19 COVID-19 cases COVID-19 vaccination COVID-19 vaccine COVID-19-related death Critical death Decline declined defined dose effective Effectiveness Emergency use estimate evaluate help hospitalisation hospitalisations Impact incidence incidence rate incidence rates individual International laboratory-confirmed SARS-CoV-2 infection Ministry of Health MoH mRNA mRNA BNT162b2 vaccine National non-proprietary name of BNT162b2 Older outcome outcomes pandemic PCR test Pfizer-BioNTech Prevalence prevelance proportion receiving Regression model SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 infections SARS-CoV-2-positive specimen second dose second dose of vaccine severe disease Sex spike gene surveillance data sustained symptomatic symptomatic and asymptomatic symptomatic COVID-19 symptomatic infection tested the vaccine vaccinated individual vaccinated individuals vaccination Vaccine was used widespread
[DOI] 10.1016/S0140-6736(21)00947-8 PMC 바로가기 [Article Type] Observational Study